Julius A. Edson

Julius A. Edson

Auto-generated profile, based on publicly available information

Julius A. Edson

Department of Chemical Engineering and Materials Science University of California Irvine CA 92697 USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2018 in Biomacromolecules
Verified
Journal Article
Closed access
JEJulius A. Edson
Julius A. Edson
DIDominique Ingato
Dominique Ingato
SWShirley Wu
Shirley Wu
BLBianca Lee
Bianca Lee
YKYoung Jik Kwon
Young Jik Kwon

15 October 2016 in Nano Convergence
Verified
Journal Article
Open access
PDF file
JEJulius A. Edson
Julius A. Edson
YKYoung Jik Kwon
Young Jik Kwon
Over the past few years, there have been calls for novel antimicrobials to combat the rise of drug-resistant bacteria. While some promising new discoveries have met this call, it is not nearly enough. The major problem is that although these new promising antimicrobials serve as a short-term solution, they lack the potential to provide a long-term solution. The conventional method of creating new antibiotics relies heavily on the discovery of an antimicrobial compound from another microbe. This paradigm of development is flawed due to the fact that microbes can easily transfer a resistant mechanism if faced with an environmental pressure. Furthermore, there has been some evidence to indicate that the environment of the microbe can provide a hint as to their virulence. Because of this, the use of materials with antimicrobial properties has been garnering interest. Nanoantibiotics, (nAbts), provide a new way to circumvent the current paradigm of antimicrobial discovery and presents a novel mechanism of attack not found in microbes yet; which may lead to a longer-term solution against drug-resistance formation. This allows for environment-specific activation and efficacy of the nAbts but may also open up and create new design methods for various applications. These nAbts provide promise, but there is still ample work to be done in their development. This review looks at possible ways of improving and optimizing nAbts by making them stimuli-responsive, then consider the challenges ahead, and industrial applications.

29 July 2016 in ACS Nano
Verified
Journal Article
Closed access
CHCheol Am Hong
Cheol Am Hong
SCSoo Kyung Cho
Soo Kyung Cho
JEJulius A. Edson
Julius A. Edson
JKJane Kim
Jane Kim
DIDominique Ingato
Dominique Ingato
YKYoung Jik Kwon
Young Jik Kwon

1 September 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
JEJulius A. Edson
Julius A. Edson
YKYoung Jik Kwon
Young Jik Kwon

18 April 2021 in Macromolecular Bioscience
Verified
Journal Article
Open access
PDF file
JEJulius A. Edson
Julius A. Edson
WCWeiping Chu
Weiping Chu
SPSteffen Porwollik
Steffen Porwollik
KTKaycee Tran
Kaycee Tran
NINathalie Iribe
Nathalie Iribe
YKYoung Jik Kwon
Young Jik Kwon
Antibiotics are highly successful against microbial infections. However, current challenges include rising antibiotic resistance rates and limited efficacy against intracellular pathogens. A novel form of a nanomaterial‐based antimicrobial agent is investigated for efficient treatment of an intracellular Salmonella enterica sv Typhimurium infection. A known antimicrobial polysaccharide, chitosan, is engineered to be readily soluble under neutral aqueous conditions for systemic administration. The modified biologic, named acid‐transforming chitosan (ATC), transforms into an insoluble, antimicrobial compound in the mildly acidic intracellular compartment. In cell culture experiments, ATC is confirmed to have antimicrobial activity against intracellular S. Typhimurium in a concentration‐ and pH‐dependent manner, without affecting the host cells, RAW264.7 macrophages. For improved cellular uptake and pharmacokinetic/pharmacodynamic properties, ATC is further complexed with fragment DNA (fDNA), to form nano‐sized spherical polyplexes. The resulting ATC/fDNA polyplexes efficiently eradicated S. Typhimurium from RAW264.7 macrophages. ATC/fDNA polyplexes may bind with microbial wall and membrane components. Consistent with this expectation, transposon insertion sequencing of a complex random mutant S. Typhimurium library incubated with ATC does not reveal specific genomic target regions of the antimicrobial. This study demonstrates the utility of a molecularly engineered nanomaterial as an efficient and safe antimicrobial agent, particularly against an intracellular pathogen.

1 January 2017
Verified
Dataset
Open access
JEJulius A. Edson
Julius A. Edson
YKYoung Jik Kwon
Young Jik Kwon
Over the past few years, there have been calls for novel antimicrobials to combat the rise of drug-resistant bacteria. While some promising new discoveries have met this call, it is not nearly enough. The major problem is that although these new promising antimicrobials serve as a short-term solution, they lack the potential to provide a long-term solution. The conventional method of creating new antibiotics relies heavily on the discovery of an antimicrobial compound from another microbe. This paradigm of development is flawed due to the fact that microbes can easily transfer a resistant mechanism if faced with an environmental pressure. Furthermore, there has been some evidence to indicate that the environment of the microbe can provide a hint as to their virulence. Because of this, the use of materials with antimicrobial properties has been garnering interest. Nanoantibiotics, (nAbts), provide a new way to circumvent the current paradigm of antimicrobial discovery and presents a novel mechanism of attack not found in microbes yet; which may lead to a longer-term solution against drug-resistance formation. This allows for environment-specific activation and efficacy of the nAbts but may also open up and create new design methods for various applications. These nAbts provide promise, but there is still ample work to be done in their development. This review looks at possible ways of improving and optimizing nAbts by making them stimuli-responsive, then consider the challenges ahead, and industrial applications.